Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease. / Thonghong, Tasalak; De Backer, Ole; Søndergaard, Lars.

I: Open Heart, Bind 5, Nr. 1, e000753, 2018.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Thonghong, T, De Backer, O & Søndergaard, L 2018, 'Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease', Open Heart, bind 5, nr. 1, e000753. https://doi.org/10.1136/openhrt-2017-000753

APA

Thonghong, T., De Backer, O., & Søndergaard, L. (2018). Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease. Open Heart, 5(1), [e000753]. https://doi.org/10.1136/openhrt-2017-000753

Vancouver

Thonghong T, De Backer O, Søndergaard L. Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease. Open Heart. 2018;5(1). e000753. https://doi.org/10.1136/openhrt-2017-000753

Author

Thonghong, Tasalak ; De Backer, Ole ; Søndergaard, Lars. / Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease. I: Open Heart. 2018 ; Bind 5, Nr. 1.

Bibtex

@article{74c192ed747445f68b9d9db3c445fb70,

title = "Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease",

abstract = "New European guidelines on the management of valvular heart disease-supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)-were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve replacement (TAVR) in the new 2017 ESC/EACTS guidelines to the essential and give additional comments on the position of TAVR in 2017.",

author = "Tasalak Thonghong and {De Backer}, Ole and Lars S{\o}ndergaard",

year = "2018",

doi = "10.1136/openhrt-2017-000753",

language = "English",

volume = "5",

journal = "Open Heart",

issn = "2398-595X",

publisher = "BMJ",

number = "1",

}

RIS

TY - JOUR

T1 - Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease

AU - Thonghong, Tasalak

AU - De Backer, Ole

AU - Søndergaard, Lars

PY - 2018

Y1 - 2018

N2 - New European guidelines on the management of valvular heart disease-supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)-were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve replacement (TAVR) in the new 2017 ESC/EACTS guidelines to the essential and give additional comments on the position of TAVR in 2017.

AB - New European guidelines on the management of valvular heart disease-supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)-were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve replacement (TAVR) in the new 2017 ESC/EACTS guidelines to the essential and give additional comments on the position of TAVR in 2017.

U2 - 10.1136/openhrt-2017-000753

DO - 10.1136/openhrt-2017-000753

M3 - Review

C2 - 29531767

VL - 5

JO - Open Heart

JF - Open Heart

SN - 2398-595X

IS - 1

M1 - e000753

ER -

ID: 216559288